Kairos Pharma’s Bhowmick presents at Discovery on Target drug discovery conference
Bitget2026/09/23 12:00- Kairos Pharma will participate in the Discovery on Target Drug Discovery Conference in Boston from Sept. 28 to Oct. 1.
- Neil Bhowmick will moderate an in-person breakout, “Winning the Race against Cancer Therapy Resistance,” on Sept. 30.
- Bhowmick will deliver a Sept. 30 main-stage presentation on KROS-101, a GITR-targeting candidate for solid tumors.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
White House National Economic Council Director Hassett questions the necessity of Fed rate hikes and criticizes some officials for advocating further tightening policies.
A senior economic official from the White House publicly questioned the necessity of the recent interest rate hikes by the Federal Reserve on Wednesday.
The wave of US Treasury sell-off continues! The largest long-term US Treasury ETF falls to its lowest level in over 20 years, dropping by half from its 2020 peak.
The U.S. long-term Treasury bond market continues to face pressure, with the largest exchange-traded fund tracking long-term U.S. Treasuries closing at its lowest level in over 20 years on Wednesday.
BUZZ-MGM Resorts shares fall after People Inc. withdraws acquisition offer
Crypto prices
More
